GANNON STEVEN 4
4 · Xenon Pharmaceuticals Inc. · Filed May 16, 2025
Insider Transaction Report
Form 4
GANNON STEVEN
Director
Transactions
- Exercise/Conversion
Common Shares
2025-05-14$12.57/sh+5,144$64,660→ 7,144 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-05-14−5,144→ 0 totalExercise: $12.57Exp: 2025-05-20→ Common Shares (5,144 underlying)
Footnotes (1)
- [F1]The shares subject to the option are fully vested and exercisable.